Stanford Cancer Institute Directory


Showing 241 - 250 of 458
    Associate Professor of Neurosurgery and, by courtesy, of Neurology and of Otolaryngology-Head and Neck Surgery at the Stanford University Medical Center
    Assistant Professor of Genetics
    Associate Professor of Urology


    Joseph Liao is currently Associate Professor of Urology at Stanford University and Chief of Urology at the Veterans Affairs Palo Alto Health Care System. He earned his A.B. in Biology from Harvard College in 1993 and M.D. from Stanford University School of Medicine in 1997. After completing his urology residency and fellowship in endourology/minimally invasive surgery at UCLA, he joined the Department of Urology at Stanford in 2006, where he is also a member of Bio-X interdisciplinary research program, Stanford Cancer Institute, and Institute for Immunity, Transplantation, and Infection. Dr. Liao is a surgeon-scientist who maintains an active clinical practice focusing on minimally invasive surgery and urologic oncology. His laboratory focuses on development and translation of optical molecular imaging for urological cancer and urine-based molecular diagnostics. Dr. Liao has pioneered the application of confocal endomicroscopy in the urinary tract, endoscopic molecular imaging of bladder cancer, an in vitro molecular diagnostics for urinary tract infections and bladder cancer. He has served as the principal investigator on several R01 grants from the National Institutes of Health, as well as a standing member of the NIH Instrument Systems Development study section. He is an author of over 100 manuscripts and the editor of the textbook Advances in Image-Guided Urologic Surgery. He has been an invited speaker to numerous international meetings including the Gordon Research Conferences, IEEE-NANOMED, IEEE-NEMS, SPIE, Society of Urologic Oncology, Endourology Society, American Urological Association, and European Association of Urology.
    Lydia J. Lee Professor in Pediatric Cancer
    Associate Professor of Bioengineering
    Professor of Pathology, of Genetics and, by courtesy, of Biology
    Clinical Instructor, Radiology


    Dr. Lipson is an investigator and faculty member in the Stanford University School of Medicine Department of Radiology, Breast Imaging Division. A graduate of Harvard College in 1995, she received her MD degree from UCSF School of Medicine, prior to completing a preliminary medicine internship year at St. Mary's Medical Center in San Francisco. She went on to complete a diagnostic radiology residency program at UCSF and was ABR board-certified in June 2009. She came to Stanford for a 1 year fellowship program in Breast Imaging in July 2009 before joining the MCL faculty in August 2010. Her clinical work includes screening and diagnostic mammography, diagnostic breast ultrasound, screening and diagnostic breast MRI, and minimally-invasive breast biopsy and wire localization guided by x-ray, ultrasound, and MRI. Her research interests include mammographic density and breast cancer risk assessment; early breast cancer detection and extent of disease evaluation using contrast enhanced mammography and MRI; novel blood and imaging biomarkers of breast cancer burden and neoadjuvant treatment response; and image-guided wireless localization techniques for breast surgery.
    Professor of Pathology (Research) at the Stanford University Medical Center
    Deane P. and Louise Mitchell Professor in the School of Medicine and Professor, by courtesy, of Bioengineering and of Materials Science and Engineering
    Associate Professor of Radiation Oncology (Radiation Therapy) at the Stanford University Medical Center


    Dr. Loo is a physician-scientist Radiation Oncologist and Bioengineer who leads the Thoracic Radiation Oncology program at Stanford Cancer Institute. His clinical specialties are state-of-the-art radiation therapy for lung/thoracic cancers, including stereotactic ablative radiotherapy (SABR) and 4-D image-guided radiation therapy for lung tumors and radiosurgery for brain metastases. His research is in clinical trials and implementation of new treatment techniques for lung cancer, development of new medical imaging methods for measuring organ function and predicting response to cancer treatment, and development of next generation radiation treatment technologies and studying their unique biological effects. Dr. Loo is a recognized expert in thoracic cancers serving on multiple national committees (including as writing member, chair, or vice-chair) that publish clinical guidelines on the treatment of lung cancer and other thoracic malignancies, including the National Comprehensive Cancer Network (NCCN), American College of Radiology (ACR), and American Society of Radiation Oncology (ASTRO). Dr. Loo received his MD from University of California, Davis and his PhD in Bioengineering from University of California, San Francisco and Berkeley. He completed his Radiation Oncology residency training at Stanford University where he is now Associate Professor of Radiation Oncology. He is certified by the American Board of Radiology in Radiation Oncology.